HDFC Bank’s shares are in focus after the lender posted a 2.2% YoY growth in net profit for Q3FY25, reaching Rs 16,736 crore, which fell short of Street estimates. The bank’s net revenue grew by 6.3%. Analysts recommend a ‘Buy’ rating due to strong asset quality and improvements in deposit market share.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.